Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Solomon

Showing results (1481-1490 of 1,873) with videos related to

Pageof 188
Sort By:
JAMA|February 17, 2012
Vitamin D therapy and cardiac structure and function in patients with chronic kidney disease: the PRIMO randomized controlled trialRavi Thadhani, Evan Appelbaum, Yili Pritchett, et al.
JAMA Cardiology|January 30, 2020
Prognostic Models Derived in PARADIGM-HF and Validated in ATMOSPHERE and the Swedish Heart Failure Registry to Predict Mortality and Morbidity in Chronic Heart FailureJoanne Simpson, Pardeep S Jhund, Lars H Lund, et al.
JAMA Cardiology|March 30, 2025
Mode of Death in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction: The FINEARTS-HF Randomized Clinical TrialAkshay S Desai, Pardeep S Jhund, Muthiah Vaduganathan, et al.
American Heart Journal|December 1, 2012
Vitamin D reduces left atrial volume in patients with left ventricular hypertrophy and chronic kidney diseaseHector Tamez, Carmine Zoccali, David Packham, et al.
Nature Medicine|August 30, 2024
Electronic nudges for sustained influenza vaccination uptake in older adults: the nationwide randomized NUDGE-FLU-2 trialNiklas Dyrby Johansen, Muthiah Vaduganathan, Ankeet S Bhatt, et al.
Annals of Internal Medicine|March 18, 2024
Clinical Outcomes With Electronic Nudges to Increase Influenza Vaccination : A Prespecified Analysis of a Nationwide, Pragmatic, Registry-Based, Randomized Implementation TrialNiklas Dyrby Johansen, Muthiah Vaduganathan, Ankeet S Bhatt, et al.
European Journal of Heart Failure|March 12, 2026
Finerenone and Quality of Life in Heart Failure: Component-Level Analyses and Clinical Relevance of the Kansas City Cardiomyopathy QuestionnaireYasuhiro Hamatani, Alexander Peikert, Brian L Claggett, et al.
Journal of the American College of Cardiology|November 7, 2015
Comparing LCZ696 with enalapril according to baseline risk using the MAGGIC and EMPHASIS-HF risk scores: an analysis of mortality and morbidity in PARADIGM-HFJoanne Simpson, Pardeep S Jhund, Jose Silva Cardoso, et al.
European Journal of Heart Failure|October 3, 2025
Interplay of serum potassium and kidney function with finerenone in heart failure with mildly reduced or preserved ejection fraction: Findings from FINEARTS-HFJoão Pedro Ferreira, Muthiah Vaduganathan, Brian L Claggett, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 11, 2017
ESRD After Heart Failure, Myocardial Infarction, or Stroke in Type 2 Diabetic Patients With CKDDavid M Charytan, Scott D Solomon, Peter Ivanovich, et al.
Pageof 188

Showing results (1481-1490 of 1,873) with videos related to

Sort By:
Pageof 188
JAMA|February 17, 2012
Vitamin D therapy and cardiac structure and function in patients with chronic kidney disease: the PRIMO randomized controlled trialRavi Thadhani, Evan Appelbaum, Yili Pritchett, et al.
JAMA Cardiology|January 30, 2020
Prognostic Models Derived in PARADIGM-HF and Validated in ATMOSPHERE and the Swedish Heart Failure Registry to Predict Mortality and Morbidity in Chronic Heart FailureJoanne Simpson, Pardeep S Jhund, Lars H Lund, et al.
JAMA Cardiology|March 30, 2025
Mode of Death in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction: The FINEARTS-HF Randomized Clinical TrialAkshay S Desai, Pardeep S Jhund, Muthiah Vaduganathan, et al.
American Heart Journal|December 1, 2012
Vitamin D reduces left atrial volume in patients with left ventricular hypertrophy and chronic kidney diseaseHector Tamez, Carmine Zoccali, David Packham, et al.
Nature Medicine|August 30, 2024
Electronic nudges for sustained influenza vaccination uptake in older adults: the nationwide randomized NUDGE-FLU-2 trialNiklas Dyrby Johansen, Muthiah Vaduganathan, Ankeet S Bhatt, et al.
Annals of Internal Medicine|March 18, 2024
Clinical Outcomes With Electronic Nudges to Increase Influenza Vaccination : A Prespecified Analysis of a Nationwide, Pragmatic, Registry-Based, Randomized Implementation TrialNiklas Dyrby Johansen, Muthiah Vaduganathan, Ankeet S Bhatt, et al.
European Journal of Heart Failure|March 12, 2026
Finerenone and Quality of Life in Heart Failure: Component-Level Analyses and Clinical Relevance of the Kansas City Cardiomyopathy QuestionnaireYasuhiro Hamatani, Alexander Peikert, Brian L Claggett, et al.
Journal of the American College of Cardiology|November 7, 2015
Comparing LCZ696 with enalapril according to baseline risk using the MAGGIC and EMPHASIS-HF risk scores: an analysis of mortality and morbidity in PARADIGM-HFJoanne Simpson, Pardeep S Jhund, Jose Silva Cardoso, et al.
European Journal of Heart Failure|October 3, 2025
Interplay of serum potassium and kidney function with finerenone in heart failure with mildly reduced or preserved ejection fraction: Findings from FINEARTS-HFJoão Pedro Ferreira, Muthiah Vaduganathan, Brian L Claggett, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 11, 2017
ESRD After Heart Failure, Myocardial Infarction, or Stroke in Type 2 Diabetic Patients With CKDDavid M Charytan, Scott D Solomon, Peter Ivanovich, et al.
Pageof 188